March 27, 2018
Novartis sells stake in consumer healthcare JV to GSK for $13.0 billion
Novartis will sell its 36.5 percent stake in its consumer healthcare joint venture (JV) to GSK for $13.0 billion, it…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: GSK
March 23, 2018
GSK’s shingles prevention vaccine approved in Europe and Japan
GlaxoSmithKline got the approval for shingles prevention, and post-herpetic neuralgia (PHN) vaccine Shingrix, in Europe, while in Japan it was registered…
March 8, 2018
GSK, Innoviva get EC’s label update, once daily Relvar Ellipta as good as as twice-daily ICS/LABA for patients with asthma
The European Commission has approved a label update for the use of GlaxoSmithKline and Innoviva’s Relvar Ellipta, an inhaled corticosteroid (ICS) / long-acting β2-agonist (LABA)…
February 8, 2018
ViiV Healthcare sues Gilead over HIV drug containing bictegravir patent infringmenet, Gilead increases dividend 10% after posting net loss in Q4 2017
ViiV Healthcare on Thursday said it has filed patent infringement litigation against Gilead Sciences Inc. over bictegravir in the United…
January 3, 2018
Trends in OTC pharma packaging
While physically over-the-counter (OTC) medicine packaging may mirror the prescription drug market, with continued strong demand for plastic primary pharmaceutical…
December 6, 2017
GSK’s Shingrix able to prevent shingles in autologous haematopoietic stem cell transplant patients
GlaxoSmithKline said on Wednesday that new data from a Phase III clinical study supports the safety and efficacy of Shingrix…
November 2, 2017
GSK’s investigational BCMA antibody-drug gets FDA breakthrough therapy designation
GlaxoSmithKline said on Thursday that its investigational BCMA antibody-drug has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration…
October 17, 2017
Plasticell, GSK ink deal to produce hematopoietic cells from iPSCs
Plasticell, the biotechnology company specialising in stem cell screening and cell therapy development, has entered into a collaboration with GSK to…
July 22, 2017
GSK submits EU filing for Relvar Ellipta extension
GlaxoSmithKline and Innoviva have asked the European Medicines Agency (EMA) to extend the use of Relvar Ellipta, a once-daily fluticasone furoate/vilanterol-based (FF/VI) inhaled corticosteroid (ICS) / combination, in patients already adequately controlled on an ICS/LABA combination.
July 20, 2017
GSK plans to cut 320 jobs
GSK on Wednesday set out several announcements made by the company to improve the efficiency and competitiveness of its manufacturing network, including investments for respiratory and HIV medicines manufacturing in the UK and strategic reviews. This includes the sale of several products and a proposal to close a UK manufacturing site.